Literature DB >> 2969913

Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy.

A Kofoed-Enevoldsen1, T Jensen, K Borch-Johnsen, T Deckert.   

Abstract

The association between the incidence of diabetic retinopathy and the development of diabetic nephropathy was studied in 110 Type I (insulin-dependent) diabetic patients during a period from 10 years before to 5 years after the onset of persistent proteinuria. This group of patients was compared with 110 diabetic patients, who were matched according to sex, age, and diabetes duration, but who were without proteinuria during the observation period. The cumulative incidence of proliferative retinopathy was 74% in patients with clinical nephropathy and 14% in patients free of proteinuria. The incidence of background retinopathy was 93% and 37%, respectively, and the incidence of retinopathy increased dramatically 5 years before the onset of proteinuria. Neither gender, age at onset of diabetes, nor blood pressure seemed to have much influence on the incidence of severe retinopathy. It is concluded that development of clinical diabetic nephropathy implies an extremely high risk of developing severe retinopathy. A common pathogenetic link may be suspected.

Entities:  

Mesh:

Year:  1987        PMID: 2969913     DOI: 10.1016/s0891-6632(87)80064-8

Source DB:  PubMed          Journal:  J Diabet Complications        ISSN: 0891-6632


  16 in total

1.  The economics of screening for microalbuminuria in patients with insulin-dependent diabetes mellitus.

Authors:  K Borch-Johnsen
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

2.  Prevalence of ocular fundus pathology in patients with chronic kidney disease.

Authors:  Juan E Grunwald; Judith Alexander; Maureen Maguire; Revell Whittock; Candace Parker; Kathleen McWilliams; Joan C Lo; Raymond Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahaboob Rahman; Harold Feldman; John Kusek; Akinlolu Ojo
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

Review 3.  The role of hypertension in the development of nephropathy in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; K Nørgaard; T Jensen; E Mathiesen; T Deckert
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

4.  Diabetic eNOS-knockout mice develop accelerated retinopathy.

Authors:  Qiuhong Li; Amrisha Verma; Ping-Yang Han; Takahiko Nakagawa; Richard J Johnson; Maria B Grant; Martha Campbell-Thompson; Yagna P R Jarajapu; Bo Lei; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

Review 5.  Can retinopathy be prevented?

Authors:  B Weber; G Hövener; W Burger; R Hartmann; I Enders
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

6.  Optimal treatment of diabetic retinopathy.

Authors:  Hans-Peter Hammes
Journal:  Ther Adv Endocrinol Metab       Date:  2013-04       Impact factor: 3.565

Review 7.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

8.  Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study.

Authors:  Juan E Grunwald; Judith Alexander; Gui-Shuang Ying; Maureen Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker; Kathleen McWilliams; Joan C Lo; Alan Go; Raymond Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie; Bernard G Jaar
Journal:  Arch Ophthalmol       Date:  2012-09

Review 9.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?

Authors:  K Borch-Johnsen; H Wenzel; G C Viberti; C E Mogensen
Journal:  BMJ       Date:  1993-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.